ThermoGenesis Holdings Inc (THMO)
0.27
+0.06
(+28.88%)
USD |
OTCM |
Sep 27, 16:00
ThermoGenesis Holdings Research and Development Expense (Annual): 1.284M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.284M |
| December 31, 2022 | 1.659M |
| December 31, 2021 | 2.209M |
| December 31, 2020 | 2.477M |
| December 31, 2019 | 2.396M |
| December 31, 2018 | 3.012M |
| December 31, 2017 | 2.246M |
| June 30, 2017 | 2.497M |
| June 30, 2016 | 3.23M |
| June 30, 2015 | 5.939M |
| June 30, 2014 | 3.468M |
| June 30, 2013 | 2.991M |
| June 30, 2012 | 3.729M |
| June 30, 2011 | 3.003M |
| June 30, 2010 | 5.013M |
| Date | Value |
|---|---|
| June 30, 2009 | 5.222M |
| June 30, 2008 | 7.172M |
| June 30, 2007 | 4.108M |
| June 30, 2006 | 4.157M |
| June 30, 2005 | 5.673M |
| June 30, 2004 | 3.472M |
| June 30, 2003 | 2.937M |
| June 30, 2002 | 2.283M |
| June 30, 2001 | 1.782M |
| June 30, 2000 | 1.624M |
| June 30, 1999 | 2.00M |
| June 30, 1998 | 3.90M |
| June 30, 1997 | 3.60M |
| June 30, 1996 | 1.30M |
| June 30, 1995 | 0.40M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
1.284M
Minimum
2023
2.477M
Maximum
2020
2.005M
Average
2.209M
Median
2021
Research and Development Expense (Annual) Benchmarks
| NeuroOne Medical Technologies Corp | 6.941M |
| SINTX Technologies Inc | 8.713M |
| Nutriband Inc | 1.960M |
| enVVeno Medical Corp | 13.58M |
| Beyond Air Inc | 24.36M |